AQUOLIVE
Financiado
Improving Aquaculture production with bioactives from olive oil processing by pr...
Natac Biotech S.L. is the R&D division of a group of 8 companies (Natac Group S.L.) with headquarters in Spain and international presence in EU, LATAM and the USA. Our group is a leading firm of the natural extracts sector and we...
Natac Biotech S.L. is the R&D division of a group of 8 companies (Natac Group S.L.) with headquarters in Spain and international presence in EU, LATAM and the USA. Our group is a leading firm of the natural extracts sector and we have developed and operated the first olive biorefinery at a global level. Thanks to this, we can obtain high added value bioactive ingredients from residues of olive oil production (circular bio-economy) at industrial quantities and very competitive prices.
In our effort to continue innovating and expanding, the AQUOLIVE project is now the most strategic project for us, as a way to become a leading player of the animal nutrition market. The AQUOLIVE project is aimed at offering the aquaculture sector a high-performance feed additive based on our patented formulation of bioactive phytochemicals obtained from olive oil production by-products (production method also patented). This solution will help Fish farmers to increase their productivity and profitability, while reducing the use of hazardous antimicrobial chemicals in intensive aquaculture practices.
Thanks to the clear benefits AQUOLIVE will bring to fish farmers and the industry need for this type of solution, we see in the AQUOLIVE project a clear investment opportunity, in which we seek entering the fast-growing aquaculture feed market. This market was value globally at €156 Billion in 2015 and project to €209 Billion by 2019. More precisely, AQUOLIVE will target the salmon feed market, with a global production of 7 MTon in 2017 and that accounts for a total of 11% share of the total production of aquafeed products globally. In this growing market scenario, our 3-years business plan after this Phase 2 project will mean a 3-years cumulative cash flow of €9.02 Million meaning a 3-years after-tax ROI of 362% for a total investment of €2.49 Million in the Phase 2 project (€1.74 M of EU contribution).
ver más
Duración del proyecto: 30 meses
Fecha Inicio: 2019-02-28
Fecha Fin: 2021-08-31
Fecha Fin: 2021-08-31
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2021-08-31
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
2M€
Líder del proyecto
NATAC BIOTECH
La investigacion cientifica y tecnica en relacion con ingredientes activosalimentarios o farmaceuticos.
Perfil tecnológico
TRL
3-4
3M
Perfil tecnológico
TRL
3-4
3M